NATIONAL
CALIFORNIA
VENTURA
mechanism
  • Stimulates beta-1 receptors and alpha receptors causing increased contractility and heart rate as well as vasoconstriction, thereby increasing systemic blood pressure and coronary blood flow; clinically, alpha effects (vasoconstriction) are greater than beta effects (inotropic and chronotropic effects)
indications
  • Hypotension or shock: Treatment of severe hypotension, cardiogenic shock, or septic shock (and other vasodilatory shock states) that persist after adequate fluid volume replacement.
contraindications
  • None
dosing

IV: Initial: 5 to 15 mcg/minute; titrate to MAP of 65; usual dose range: 2 to 80 mcg/minute

administration
IV Continuous Infusion
onset

Very rapid

duration

1 to 2 minutes

notes
  • Abrupt discontinuation: Gradually reduce infusion rate while expanding blood volume with IV fluids during discontinuation of therapy; severe hypotension may occur with abrupt discontinuation.
  • Appropriate use: Hypovolemia should be corrected before giving norepinephrine
dosage form
1 mg/mL (4 mL)
brand name
Levophed
adverse reactions
  • Cardiovascular
    • Cardiac arrhythmia, cardiomyopathy, peripheral vascular insufficiency
  • Central nervous system
    • Anxiety, headache
  • Respiratory
    • Dyspnea
structure
norepinephrine.svg molecular structure